A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...
Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.
Feeling overwhelmed can trigger the body's fight-or-flight response, causing unsteadiness, weak knees, or lightheadedness, often influenced by emotions, stress, or underlying health conditions.